Matthew A Ingham (Matthew Ingham)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 9

Top Topics

Multiple Myeloma

Acute Lymphoblastic Leukemia

Inflammatory Response

Small Cell Lung Cancer

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

JCO precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Brian Andrew Van Tine, Matthew A Ingham, Steven Attia, Christian F Meyer, John D Baird, Esther Brooks-Asplund, Dhiren D'Silva, Ronald Kong, Anthony Mwatha, Kylie O'Keefe, Marla Weetall, Robert Spiegel, Gary K Schwartz
Phase Ib Study of Unesbulin (PTC596) Plus Dacarbazine for the Treatment of Locally Recurrent, Unresectable or Metastatic, Relapsed or Refractory Leiomyosarcoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (20) (2024)
Karan Luthria, Parin Shah, Blake Caldwell, Johannes C Melms, Sinan Abuzaid, Viktoria Jakubikova, D Zack Brodtman, Sminu Bose, Amit Dipak Amin, Patricia Ho, Jana Biermann, Somnath Tagore, Matthew A Ingham, Gary K Schwartz, Benjamin Izar
Single-cell profiling of sarcomas from archival tissue reveals programs associated with resistance to immune checkpoint blockade. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Brian Andrew Van Tine, Matthew A Ingham, Steven Attia, Christian F Meyer, John D Baird, Esther Brooks-Asplund, Dhiren D'Silva, Ronald Kong, Anthony Mwatha, Kylie O'Keefe, Marla Weetall, Robert Spiegel, Gary K Schwartz
Phase Ib Study of Unesbulin (PTC596) Plus Dacarbazine for the Treatment of Locally Recurrent, Unresectable or Metastatic, Relapsed or Refractory Leiomyosarcoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (20) (2024)
Brian Andrew Van Tine, Matthew A Ingham, Steven Attia, Christian F Meyer, John D Baird, Esther Brooks-Asplund, Dhiren D'Silva, Ronald Kong, Anthony Mwatha, Kylie O'Keefe, Marla Weetall, Robert Spiegel, Gary K Schwartz
Phase Ib Study of Unesbulin (PTC596) Plus Dacarbazine for the Treatment of Locally Recurrent, Unresectable or Metastatic, Relapsed or Refractory Leiomyosarcoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Brian Andrew Van Tine, Matthew A Ingham, Steven Attia, Christian F Meyer, John D Baird, Esther Brooks-Asplund, Dhiren D'Silva, Ronald Kong, Anthony Mwatha, Kylie O'Keefe, Marla Weetall, Robert Spiegel, Gary K Schwartz
Phase Ib Study of Unesbulin (PTC596) Plus Dacarbazine for the Treatment of Locally Recurrent, Unresectable or Metastatic, Relapsed or Refractory Leiomyosarcoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (20) (2024)
Matthew A Ingham, Jacob B Allred, Li Chen, Biswasjit Das, Bose S Kochupurakkal, Katherine Gano, Suzanne George, Steven Attia, Melissa A Burgess, Mahesh Seetharam, Sosipatros A Boikos, Nam Q Bui, James L Chen, Julia L Close, Gregory M Cote, Premal H Thaker, Susan Percy Ivy, Sminu Bose, Alan D' Andrea, Adrian Mariño-Enriquez, Geoffrey I Shapiro, Gary K Schwartz
Phase II Study of Olaparib and Temozolomide for Advanced Uterine Leiomyosarcoma (NCI Protocol 10250). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Matthew A Ingham, Shing M Lee, Brian Andrew Van Tine, Edwin Choy, Jay Oza, Sahil D Doshi, Liner Ge, Peter Oppelt, Gregory M Cote, Brian Corgiat, Naomi Sender, Sarah Sta Ana, Lavan Panchalingam, Emanuel F Petricoin, Gary K Schwartz
A Single-Arm Phase II Trial of Sitravatinib in Advanced Well-Differentiated/Dedifferentiated Liposarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (6) (2023)
Matthew A Ingham, Shing M Lee, Brian Andrew Van Tine, Edwin Choy, Jay Oza, Sahil D Doshi, Liner Ge, Peter Oppelt, Gregory M Cote, Brian Corgiat, Naomi Sender, Sarah Sta Ana, Lavan Panchalingam, Emanuel F Petricoin, Gary K Schwartz
A single-arm phase 2 trial of Sitravatinib in advanced well-differentiated/dedifferentiated liposarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Sminu Bose, Tristan Y Lee, Shaelyn Choi, Ladan Fazlollahi, Michael J Rasiej, Gary K Schwartz, Matthew A Ingham
CDK4/6 Inhibition With Anti-PD-1 Checkpoint Blockade Induces Major Response in Aggressive Classic Kaposi Sarcoma After Previous Progression on Anti-PD-1 Alone. JCO precision oncology 6 (2022)